The germline variant P1275L was observed in myeloproliferative neoplasms and in EGFR‐mutated tumors (Jiang et al., 2018; Pratz et al., 2016), but its role in both prostate and breast cancer should be further investigated. The gene discussed is EGFR; the disease is myeloproliferative disorder.